Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 7/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.45 |
| ▸ | MMP13 | P45452 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12295435 | 0.94 | CYP2C9 (0.68) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL17590032 | 0.92 | CYP2C9 (0.63) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL2402348 | 0.91 | CYP2C9 (0.68) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL12294629 | 0.91 | CYP2C9 (0.63) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL14761082 | 0.89 | CYP2C9 (0.83) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL12295420 | 0.88 | CYP2C9 (0.73) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL16447601 | 0.87 | CYP2C9 (0.77) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL12296317 | 0.86 | CYP2C9 (0.66) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL13837938 | 0.86 | CYP2C9 (0.66) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL12295656 | 0.86 | CYP2C9 (0.87) | CYP2C9CYP2C19CYP3A4HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130065884-A1 | Anti-Infective Compounds | INSTITUT PASTEUR KOREA (KR) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065884-A1 | Anti-Infective Compounds | RABGGTB, ELANE, SERPINB1 | CYP2C9 4235/4885CYP2C19 4181/4885CYP3A4 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.